다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cellular and molecular gastroenterology and hepatology, v.1 no.3, 2015년, pp.275 - 284
Llorente, Cristina , Schnabl, Bernd
AI-Helper
The leaky gut hypothesis links translocating microbial products with the onset and progression of liver disease, and for a long time they were considered one of its major contributors. However, a more detailed picture of the intestinal microbiota contributing to liver disease started to evolve. The ...
1 Qin J. Li R. Raes J. A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 59 65 20203603
2 Sonnenburg J.L. Xu J. Leip D.D. Glycan foraging in vivo by an intestine-adapted bacterial symbiont Science 307 2005 1955 1959 15790854
3 Yatsunenko T. Rey F.E. Manary M.J. Human gut microbiome viewed across age and geography Nature 486 2012 222 227 22699611
4 Olszak T. An D. Zeissig S. Microbial exposure during early life has persistent effects on natural killer T cell function Science 336 2012 489 493 22442383
5 Uematsu S. Fujimoto K. Jang M.H. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5 Nat Immunol 9 2008 769 776 18516037
6 Ley R.E. Turnbaugh P.J. Klein S. Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023 17183309
7 Kau A.L. Ahern P.P. Griffin N.W. Human nutrition, the gut microbiome and the immune system Nature 474 2011 327 336 21677749
8 Frank D.N. St Amand A.L. Feldman R.A. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci USA 104 2007 13780 13785 17699621
9 Hsiao E.Y. McBride S.W. Hsien S. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders Cell 155 2013 1451 1463 24315484
10 Yoshimoto S. Loo T.M. Atarashi K. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome Nature 499 2013 97 101 23803760
11 Schnabl B. Transplanting a fibrogenic microbiota Hepatology 59 2014 1660 1661 24676698
12 Hartmann P. Chen P. Wang H.J. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice Hepatology 58 2013 108 119 23408358
13 Grivennikov S.I. Wang K. Mucida D. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258 23034650
14 Yan A.W. Fouts D.E. Brandl J. Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 2011 96 105 21254165
15 Zhu L. Baker S.S. Gill C. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH Hepatology 57 2013 601 609 23055155
16 Chen P. Starkel P. Turner J.R. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice Hepatology 61 2015 883 894 25251280
17 Turnbaugh P.J. Hamady M. Yatsunenko T. A core gut microbiome in obese and lean twins Nature 457 2009 480 484 19043404
18 Jumpertz R. Le D.S. Turnbaugh P.J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans Am J Clin Nutr 94 2011 58 65 21543530
19 Backhed F. Ding H. Wang T. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci USA 101 2004 15718 15723 15505215
20 Leclercq S. Matamoros S. Cani P.D. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity Proc Natl Acad Sci USA 111 2014 E4485 E4493 25288760
21 Bode J.C. Bode C. Heidelbach R. Jejunal microflora in patients with chronic alcohol abuse Hepatogastroenterology 31 1984 30 34 6698486
22 Mutlu E.A. Gillevet P.M. Rangwala H. Colonic microbiome is altered in alcoholism Am J Physiol Gastrointest Liver Physiol 302 2012 G966 G978 22241860
23 Mutlu E. Keshavarzian A. Engen P. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats Alcohol Clin Exp Res 33 2009 1836 1846 19645728
24 Bull-Otterson L. Feng W. Kirpich I. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment PloS One 8 2013 e53028 23326376
25 Chen P. Torralba M. Tan J. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice Gastroenterology 148 2015 203 214 e216 25239591
26 Wang Y. Kirpich I. Liu Y. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury Am J Pathol 179 2011 2866 2875 22093263
27 Brandl K. Plitas G. Mihu C.N. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits Nature 455 2008 804 807 18724361
28 Cho I. Yamanishi S. Cox L. Antibiotics in early life alter the murine colonic microbiome and adiposity Nature 488 2012 621 626 22914093
29 Hildebrand H. Malmborg P. Askling J. Early-life exposures associated with antibiotic use and risk of subsequent Crohn’s disease Scand J Gastroenterol 43 2008 961 966 19086166
30 Card T. Logan R.F. Rodrigues L.C. Antibiotic use and the development of Crohn’s disease Gut 53 2004 246 250 14724158
31 Gilat T. Hacohen D. Lilos P. Langman M.J. Childhood factors in ulcerative colitis and Crohn’s disease: an international cooperative study Scand J Gastroenterol 22 1987 1009 1024 3685876
32 Dominguez-Bello M.G. Costello E.K. Contreras M. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc Natl Acad Sci USA 107 2010 11971 11975 20566857
33 Charlson E.S. Chen J. Custers-Allen R. Disordered microbial communities in the upper respiratory tract of cigarette smokers PloS One 5 2010 e15216 21188149
34 Benjamin J.L. Hedin C.R. Koutsoumpas A. Smokers with active Crohn’s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota Inflamm Bowel Dis 18 2012 1092 1100 22102318
35 Biedermann L. Zeitz J. Mwinyi J. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans PloS One 8 2013 e59260 23516617
36 Walk S.T. Blum A.M. Ewing S.A. Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus Inflamm Bowel Dis 16 2010 1841 1849 20848461
37 Lee S. Sung J. Lee J. Comparison of the gut microbiotas of healthy adult twins living in South Korea and the United States Appl Environ Microbiol 77 2011 7433 7437 21873488
38 Dicksved J. Halfvarson J. Rosenquist M. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease ISME J 2 2008 716 727 18401439
39 Benson A.K. Kelly S.A. Legge R. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors Proc Natl Acad Sci USA 107 2010 18933 18938 20937875
40 Goodrich J.K. Waters J.L. Poole A.C. Human genetics shape the gut microbiome Cell 159 2014 789 799 25417156
41 Knights D. Silverberg M.S. Weersma R.K. Complex host genetics influence the microbiome in inflammatory bowel disease Genome Med 6 2014 107 25587358
42 Bruns T. Peter J. Reuken P.A. NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis Liver Int 32 2012 223 230 21745302
43 Appenrodt B. Grunhage F. Gentemann M.G. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis Hepatology 51 2010 1327 1333 20087966
44 Saner F.H. Nowak K. Hoyer D. A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients BMC Gastroenterol 14 2014 4 24393249
45 Elinav E. Strowig T. Kau A.L. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis Cell 145 2011 745 757 21565393
46 Henao-Mejia J. Elinav E. Jin C. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185 22297845
47 Hedin C.R. McCarthy N.E. Louis P. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn’s disease and their unaffected siblings Gut 63 2014 1578 1586 24398881
48 Hooper L.V. Littman D.R. Macpherson A.J. Interactions between the microbiota and the immune system Science 336 2012 1268 1273 22674334
49 Swidsinski A. Sydora B.C. Doerffel Y. Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota Inflamm Bowel Dis 13 2007 963 970 17455202
50 Sommer F. Backhed F. The gut microbiota—masters of host development and physiology Nat Rev Microbiol 11 2013 227 238 23435359
51 Yang D. Chertov O. Oppenheim J.J. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37) J Leukoc Biol 69 2001 691 697 11358975
52 Kubinak J.L. Petersen C. Stephens W.Z. MyD88 Signaling in T cells directs IgA-mediated control of the microbiota to promote health Cell Host Microbe 17 2015 153 163 25620548
53 Macpherson A.J. Gatto D. Sainsbury E. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria Science 288 2000 2222 2226 10864873
54 Kawamoto S. Tran T.H. Maruya M. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut Science 336 2012 485 489 22539724
55 Petnicki-Ocwieja T. Hrncir T. Liu Y.J. Nod2 is required for the regulation of commensal microbiota in the intestine Proc Natl Acad Sci USA 106 2009 15813 15818 19805227
56 Salzman N.H. Hung K. Haribhai D. Enteric defensins are essential regulators of intestinal microbial ecology Nat Immunol 11 2010 76 83 19855381
57 Vaishnava S. Yamamoto M. Severson K.M. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine Science 334 2011 255 258 21998396
58 Teltschik Z. Wiest R. Beisner J. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense Hepatology 55 2012 1154 1163 22095436
59 Johansson M.E. Larsson J.M. Hansson G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions Proc Natl Acad Sci USA 108 Suppl 1 2011 4659 4665 20615996
60 Juge N. Microbial adhesins to gastrointestinal mucus Trends Microbiol 20 2012 30 39 22088901
61 Derrien M. van Passel M.W. van de Bovenkamp J.H. Mucin-bacterial interactions in the human oral cavity and digestive tract Gut Microbes 1 2010 254 268 21327032
62 Zarepour M. Bhullar K. Montero M. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis Infect Immun 81 2013 3672 3683 23876803
63 Sovran B. Loonen L.M. Lu P. IL-22-STAT3 pathway plays a key role in the maintenance of ileal homeostasis in mice lacking secreted mucus barrier Inflamm Bowel Dis 21 2015 531 542 25636123
64 Qin N. Yang F. Li A. Alterations of the human gut microbiome in liver cirrhosis Nature 513 2014 59 64 25079328
65 Scobie B.A. Summerskill W.H. Reduced gastric acid output in cirrhosis: quantitation and relationships Gut 5 1964 422 428 14218260
66 Lu H. Wu Z. Xu W. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients Microb Ecol 61 2011 693 703 21286703
67 Schnabl B. Brenner D.A. Interactions between the intestinal microbiome and liver diseases Gastroenterology 146 2014 1513 1524 24440671
68 Hartmann P. Seebauer C.T. Schnabl B. Alcoholic liver disease: the gut microbiome and liver crosstalk Alcohol Clin Exp Res 39 2015 763 775 25872593
69 De Minicis S. Rychlicki C. Agostinelli L. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice Hepatology 59 2014 1738 1749 23959503
70 Cani P.D. Amar J. Iglesias M.A. Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772 17456850
71 Teixeira T.F. Souza N.C. Chiarello P.G. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors Clin Nutr 31 2012 735 740 22444236
72 Miele L. Valenza V. La Torre G. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887 19291785
73 Keshavarzian A. Fields J.Z. Vaeth J. Holmes E.W. The differing effects of acute and chronic alcohol on gastric and intestinal permeability Am J Gastroenterol 89 1994 2205 2211 7977243
74 Pendyala S. Neff L.M. Suarez-Farinas M. Holt P.R. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis Am J Clin Nutr 93 2011 234 242 21147860
75 Ding S. Chi M.M. Scull B.P. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse PLoS One 5 2010 e12191 20808947
76 Amar J. Burcelin R. Ruidavets J.B. Energy intake is associated with endotoxemia in apparently healthy men Am J Clin Nutr 87 2008 1219 1223 18469242
77 Erridge C. Attina T. Spickett C.M. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation Am J Clin Nutr 86 2007 1286 1292 17991637
78 Alisi A. Manco M. Devito R. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children J Pediatr Gastroenterol Nutr 50 2010 645 649 20400911
79 Farhadi A. Gundlapalli S. Shaikh M. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis Liver Int 28 2008 1026 1033 18397235
80 Garcia-Tsao G. Lee F.Y. Barden G.E. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites Gastroenterology 108 1995 1835 1841 7768390
81 Saitoh O. Sugi K. Lojima K. Increased prevalence of intestinal inflammation in patients with liver cirrhosis World J Gastroenterol 5 1999 391 396 11819475
82 Du Plessis J. Vanheel H. Janssen C.E. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function J Hepatol 58 2013 1125 1132 23402745
83 Wiest R. Lawson M. Geuking M. Reply to: “Bacterial translocation in liver cirrhosis: site and role in fibrogenesis” J Hepatol 61 2014 710 711 24929092
84 Wiest R. Lawson M. Geuking M. Pathological bacterial translocation in liver cirrhosis J Hepatol 60 2014 197 209 23993913
85 Uesugi T. Froh M. Arteel G.E. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice Hepatology 34 2001 101 108 11431739
86 Hritz I. Mandrekar P. Velayudham A. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 Hepatology 48 2008 1224 1231 18792393
87 Seki E. De Minicis S. Osterreicher C.H. TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332 17952090
88 Hartmann P. Haimerl M. Mazagova M. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice Gastroenterology 143 2012 1330 1340 e1331 22841787
89 Saberi M. Woods N.B. de Luca C. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice Cell Metab 10 2009 419 429 19883619
90 Miura K. Kodama Y. Inokuchi S. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1 beta in mice Gastroenterology 139 2010 323 334 e327 20347818
91 Rivera C.A. Adegboyega P. van Rooijen N. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J Hepatol 47 2007 571 579 17644211
92 Cani P.D. Bibiloni R. Knauf C. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481 18305141
93 Adachi Y. Moore L.E. Bradford B.U. Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 1995 218 224 7806045
94 Douhara A. Moriya K. Yoshiji H. Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model Mol Med Rep 11 2015 1693 1700 25421042
95 Bode C. Schafer C. Fukui H. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease—a double-blind, placebo-controlled trial Alcohol Clin Exp Res 21 1997 1367 1373 9394106
96 Bass N.M. Mullen K.D. Sanyal A. Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071 1081 20335583
97 Mazagova M. Wang L. Anfora A.T. Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice FASEB J 29 2015 1043 1055 25466902
98 Wikoff W.R. Anfora A.T. Liu J. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc Natl Acad Sci USA 106 2009 3698 3703 19234110
99 Venkatesh M. Mukherjee S. Wang H. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4 Immunity 41 2014 296 310 25065623
100 Abu-Shanab A. Quigley E.M. The role of the gut microbiota in nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 691 701 21045794
101 Hildebrandt M.A. Hoffmann C. Sherrill-Mix S.A. High-fat diet determines the composition of the murine gut microbiome independently of obesity Gastroenterology 137 2009 1716 1724 e1–2 19706296
102 Conterno L. Fava F. Viola R. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6 2011 241 260 21559992
103 Backhed F. Manchester J.K. Semenkovich C.F. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc Natl Acad Sci USA 104 2007 979 984 17210919
104 Ridaura V.K. Faith J.J. Rey F.E. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214 24009397
105 Turnbaugh P.J. Ley R.E. Mahowald M.A. An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031 17183312
106 Nair S. Cope K. Risby T.H. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis Am J Gastroenterol 96 2001 1200 1204 11316170
107 Cope K. Risby T. Diehl A.M. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis Gastroenterology 119 2000 1340 1347 11054393
108 Hartmann P. Chen W.C. Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease Front Physiol 3 2012 402 23087650
109 Jokelainen K. Roine R.P. Vaananen H. In vitro acetaldehyde formation by human colonic bacteria Gut 35 1994 1271 1274 7959236
110 Abdelmegeed M.A. Banerjee A. Jang S. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis Free Radic Biol Med 65 2013 1238 1245 24064383
111 Forsyth C.B. Voigt R.M. Shaikh M. Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability Am J Physiol Gastrointest Liver Physiol 305 2013 G185 G195 23660503
112 Rao R.K. Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer Methods Mol Biol 447 2008 171 183 18369919
113 Dumas M.E. Barton R.H. Toye A. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc Natl Acad Sci USA 103 2006 12511 12516 16895997
114 Jiang X.C. Li Z. Liu R. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants J Biol Chem 280 2005 18336 18340 15734742
115 Blumberg H. McCollum E.V. The prevention by choline of liver cirrhosis in rats on high fat, low protein diets Science 93 1941 598 599 17795968
116 Spencer M.D. Hamp T.J. Reid R.W. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency Gastroenterology 140 2011 976 986 21129376
117 Rehman A. Sina C. Gavrilova O. Nod2 is essential for temporal development of intestinal microbial communities Gut 60 2011 1354 1362 21421666
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.